HSE enter 'final stages' of talks for Cystic Fibrosis drug Orkambi

The HSE will today enter the 'final stages' of talks to agree the price of a major new drug for Cystic Fibrosis.

HSE enter 'final stages' of talks for Cystic Fibrosis drug Orkambi

The HSE will today enter the 'final stages' of talks to agree the price of a major new drug for Cystic Fibrosis.

Senior management will spend the rest of the week in discussions with Vertex over the cost of the drug Orkambi.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited